2m 2m 2m 2m 2m 2m 2m
Revelatn Bio (REVB)
NASDAQ
$3.67-$0.01 (-0.27%)
Price as of Oct 22, 2026 7:30 PM EDT- $14.3MMarket Cap
- -89.10%1-Year Change
- BiotechnologyIndustry
Revelatn Bio (REVB)
$3.67-$0.01 (-0.27%)
REVB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.68 | ||
Change | +$0.08 (+2.22%) | ||
Open | $3.67 | ||
High | $3.85 | ||
Low | $3.60 | ||
Previous Close | $3.60 | ||
Volume | 35,543 | ||
30-Day Average Volume | 19,826 | ||
1-Week Change | -31.03% | ||
1-Month Change | -46.36% | ||
1-Year Change | -89.14% | ||
3-Year Change | -99.99% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 4.0M | ||
Total Assets | $12.5M | ||
Market Cap | $14.3M | ||
Enterprise Value | $2.9M | ||
Period: QTR TTM FY | |||
Revenue | $82,159.00 | ||
Net Income | -$3.3M | ||
Free Cash Flow | -$2.6M | ||
EBIT | -$3.3M | ||
EBITDA | -$3.3M | ||
Net Working Capital | $9.8M | ||
EPS | -$6.09 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 35 | ||
P/B | 1 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 7 | ||
Last Split Date | 10/20/2026 | ||
Earnings & Revenue